Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

643
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
643
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.4K
The pathophysiology of pneumonia involves the following steps:
2.4K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

409
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
409
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

361
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
361
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.

American journal of respiratory and critical care medicine·2026
Same author

Co-designing a Palliative Care Referral Tool for Patients with Fibrosing Interstitial Lung Disease.

Annals of the American Thoracic Society·2026
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026
Same author

A statistical model for lung function trajectory and mortality in patients with fibrotic interstitial lung disease.

American journal of respiratory and critical care medicine·2026
Same author

Deep-Learning Algorithm Diagnostic Support for Usual Interstitial Pneumonia Pattern Recognition in Fibrotic Interstitial Lung Disease.

Respirology (Carlton, Vic.)·2026
Same author

Characterising Patient Pathways Prior to the Diagnosis of Interstitial Lung Disease.

Respirology (Carlton, Vic.)·2026

Related Experiment Video

Updated: Dec 24, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K

Nonspecific Interstitial Pneumonia.

Alan K Y Teoh1,2,3, Tamera J Corte1,2,3

  • 1Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Seminars in Respiratory and Critical Care Medicine
|April 13, 2020
PubMed
Summary

Nonspecific interstitial pneumonia (NSIP) is a complex lung disorder often linked to autoimmune conditions. Diagnosis and management are challenging due to varied presentations and evolving treatment options.

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.7K
Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

796

Related Experiment Videos

Last Updated: Dec 24, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.7K
Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

796

Area of Science:

  • Pulmonology
  • Rheumatology
  • Immunology

Background:

  • Nonspecific interstitial pneumonia (NSIP) is a complex lung disorder frequently associated with connective tissue diseases (CTDs) and environmental factors.
  • While idiopathic NSIP is recognized, some cases exhibit autoimmune features, suggesting underlying CTDs.
  • NSIP generally has a better prognosis than idiopathic pulmonary fibrosis but an unpredictable course.

Purpose of the Study:

  • To highlight the diagnostic complexities and evolving management strategies for nonspecific interstitial pneumonia (NSIP).
  • To underscore the need for a multidisciplinary approach in diagnosing and managing NSIP.
  • To discuss the current and emerging therapeutic options for NSIP.

Main Methods:

  • Review of current literature on NSIP diagnosis, pathogenesis, and management.
  • Analysis of clinical, radiological, and histological features of NSIP.
  • Evaluation of treatment strategies, including immunosuppressive, immunomodulatory, and antifibrotic agents.

Main Results:

  • NSIP diagnosis is challenging due to non-specific clinical, radiological, and histological features.
  • A significant proportion of idiopathic NSIP cases may have underlying autoimmune associations.
  • Optimal management strategies lack consensus, requiring individualized approaches and close monitoring.

Conclusions:

  • Accurate NSIP diagnosis necessitates a multidisciplinary approach due to its complex and variable presentation.
  • Early therapeutic goal clarification and diligent monitoring are crucial for managing NSIP.
  • The therapeutic landscape for NSIP is evolving, with ongoing exploration of novel agents like antifibrotics.